MedTech Acquisition Co. (OTCMKTS:MTACU – Get Free Report)’s share price was up 19.5% on Friday . The stock traded as high as $11.35 and last traded at $11.35. 1,900 shares changed hands during mid-day trading, an increase of 225% from the average daily volume of 585 shares. The stock had previously closed at $9.50.
MedTech Acquisition Stock Performance
The business’s 50 day simple moving average is $11.35 and its 200-day simple moving average is $11.35.
About MedTech Acquisition
MedTech Acquisition Corporation is a special purpose acquisition company formed in 2021 under the laws of Delaware and listed on the OTC Markets. The company’s primary objective is to complete a business combination with one or more businesses in the medical technology or life sciences sectors. By structuring as a blank check company, MedTech Acquisition seeks to leverage public market capital and strategic support to accelerate growth in a highly innovative industry.
MedTech Acquisition targets companies operating in areas such as diagnostic imaging, minimally invasive devices, regenerative medicine and digital health.
Read More
- Five stocks we like better than MedTech Acquisition
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
